Saturday, October 3, 2026

EUR/CHF Falls By 1% In The Last 5 Sessions

ViaNews Editorial Team

January 29, 2024

EUR/CHF Falls By 1% In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.28% for the last 5 sessions. At 15:06 EST on Monday, 29 January, EUR/CHF (EURCHF) is $0.93.

EUR/CHF's yearly highs and lows, it's 3.355% up from its 52-week low and 7.236% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.21%, a negative 0.01%, and a positive 0.25%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.21% (last week), 0.23% (last month), and 0.25% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd signal: broadening wedge forms ahead of fed decision - 29 January 2024. According to DailyForex on Monday, 29 January, "The EUR/USD exchange rate reacted mildly to last week's ECB decision, US GDP and December's PCE report. ", "The EUR/USD exchange rate has moved sideways in the past few days as focus now shifts to the upcoming Fed decision. "
  • Eur/usd finds six-week low near 1.0800 as euro broadly underperforms. According to FXStreet on Monday, 29 January, "Monday saw EUR/USD decline over eight-tenths of a percent peak-to-trough from Friday's near-term peak at 1.0886, and the pair continues to waffle below the 200-hour Simple Moving Average (SMA) descending into 1.0870.", "Technical resistance has piled up in a familiar zone just below the 1.0900 handle, capping off intraday momentum to the top side and chaining EUR/USD into a defensive position as bids test old chart territory."
  • Eur/usd remains under pressure below 1.0850, German GDP data eyed. According to FXStreet on Monday, 29 January, "This, in turn, might exert some selling on the Euro (EUR) and act as a headwind for the EUR/USD pair."
  • According to DailyForex on Monday, 29 January, "Presently, the EUR/USD pair price seems to be caught in a phase of indecision, oscillating within its established range as it accumulates enough momentum for a significant directional move.", "The EUR/USD pair initially showed a decline at the start of Friday's session but received substantial support at the 200-day Exponential Moving Average. "
  • Eur/usd price analysis: inches lower to 1.0840 followed by the monthly low. According to FXStreet on Monday, 29 January, "The significant level at 1.0850 may act as immediate resistance for the EUR/USD pair. ", "The 14-day Relative Strength Index (RSI) for the EUR/USD pair lies below the 50 mark, indicating a bearish momentum in the market. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com